I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Cost-effectiveness of resuvastatin in comparison with gener..:
Gandhi, Sanya K
;
Jensen, Marie M
;
Fox, Kathleen M
...
ClinicoEconomics and Outcomes Research, 2012, 4, s. 1-11. , 2012
Link:
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-88576
RT Journal T1
Cost-effectiveness of resuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events
UL https://suche.suub.uni-bremen.de/peid=base-ftlinkoepinguniv:oai:DiVA.org:liu-88576&Exemplar=1&LAN=DE A1 Gandhi, Sanya K A1 Jensen, Marie M A1 Fox, Kathleen M A1 Smolen, Lee A1 Olsson, Anders A1 Paulsson, Thomas PB Linköpings universitet, Internmedicin; Linköpings universitet, Hälsouniversitetet; Östergötlands Läns Landsting, Endokrinmedicinska kliniken; AstraZeneca LP, Wilmington, DE, USA; AstraZeneca, Lund, Sweden; Strategic HealthCare Solution, Monkton, MD, USA; Medical Decision Modeling Inc, Indianapolis, IN, USA; AstraZeneca, Södertälje, Sweden; Dove Medical Press YR 2012 K1 cardiovascular disease K1 cost-benefit analysis K1 cost-effectiveness K1 rosuvastatin K1 simvastatin K1 atorvastatin K1 generic K1 high risk K1 Medical and Health Sciences K1 Medicin och hälsovetenskap JF ClinicoEconomics and Outcomes Research, 2012, 4, s. 1-11 LK http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-88576 DO http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-88576 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)